At the news
? NEUTRALIMPACT 2/10 144 filed Nov 12, 2026 at 10:23 ET
Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 notice of intent to sell 15,286 shares of common stock, with an estimated market value of approximately $8.37 million based on the filing. The shares were acquired through ESPP purchases and restricted stock vesting between 2023 and 2025. The sale is scheduled for November 12, 2026.
- Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 on November 12, 2026.
- The filing indicates intent to sell 15,286 shares of common stock.
- Estimated aggregate market value of the proposed sale is $8,374,740.82.
- Shares were acquired through ESPP purchases and restricted stock vesting between November 2023 and May 2025.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access